Patents Assigned to Vaxeal Research SAS
  • Publication number: 20200061173
    Abstract: The present invention relates to immunogenic compositions, in particular, immunogenic compositions comprising at least one peptide derived from survivin, or a functional derivative thereof. Uses of the immunogenic compositions in the treatment of cancer, in particular a cancer over-expressing survivin are also disclosed.
    Type: Application
    Filed: March 15, 2017
    Publication date: February 27, 2020
    Applicant: Vaxeal Research SAS
    Inventors: Ahmed Bouzidi, Jérôme Kerzerho